{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:50:13Z","timestamp":1794473413049,"version":"4.9.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Science and Technology Project Plan of Liaoning Province","award":["2024JH6\/100700015"],"award-info":[{"award-number":["2024JH6\/100700015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s40263-025-01211-6","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T18:54:35Z","timestamp":1754333675000},"page":"1037-1046","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dual Antiplatelet Therapy Versus Alteplase for Mild Stroke with Admission NIHSS Score 0\u20133 Versus 4\u20135: A Secondary Analysis of the ARAMIS Randomized Trial"],"prefix":"10.1007","volume":"39","clinical-trial-number":[{"clinical-trial-number":"nct03661411","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Zhao-Xia","family":"Fei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh N.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7486-1992","authenticated-orcid":false,"given":"Hui-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"issue":"5","key":"1211_CR1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/jamaneurol.2019.5061","volume":"77","author":"H Saber","year":"2020","unstructured":"Saber H, Saver JL. Distributional validity and prognostic power of the National Institutes of Health Stroke Scale in US administrative claims data. JAMA Neurol. 2020;77(5):606\u201312.","journal-title":"JAMA Neurol"},{"issue":"4","key":"1211_CR2","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1161\/STROKEAHA.120.031329","volume":"52","author":"Y Xiong","year":"2021","unstructured":"Xiong Y, Gu H, Zhao XQ, et al. Clinical characteristics and in-hospital outcomes of varying definitions of minor stroke: from a large-scale nation-wide longitudinal registry. Stroke. 2021;52(4):1253\u20138.","journal-title":"Stroke"},{"issue":"1","key":"1211_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","volume":"369","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369(1):11\u20139.","journal-title":"N Engl J Med"},{"issue":"3","key":"1211_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","volume":"379","author":"SC Johnston","year":"2018","unstructured":"Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018;379(3):215\u201325.","journal-title":"N Engl J Med"},{"issue":"24","key":"1211_CR5","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1001\/jama.2023.7827","volume":"329","author":"HS Chen","year":"2023","unstructured":"Chen HS, Cui Y, Zhou ZH, et al. Dual antiplatelet therapy vs alteplase for patients with minor nondisabling acute ischemic stroke: the ARAMIS randomized clinical trial. JAMA. 2023;329(24):2135\u201344.","journal-title":"JAMA"},{"issue":"4","key":"1211_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1161\/STROKEAHA.123.045495","volume":"55","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Lv T, Nguyen TN, et al. Intravenous alteplase versus best medical therapy for patients with minor stroke: a systematic review and meta-analysis. Stroke. 2024;55(4):883\u201392.","journal-title":"Stroke"},{"issue":"3","key":"1211_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1177\/23969873241237312","volume":"9","author":"A Alhazzani","year":"2024","unstructured":"Alhazzani A, Al-Ajlan FS, Alkhiri A, et al. Intravenous alteplase in minor nondisabling ischemic stroke: a systematic review and meta-analysis. Eur Stroke J. 2024;9(3):521\u20139.","journal-title":"Eur Stroke J"},{"issue":"10444","key":"1211_CR8","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1016\/S0140-6736(24)00921-8","volume":"403","author":"SB Coutts","year":"2024","unstructured":"Coutts SB, Ankolekar S, Appireddy R, et al. Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial. Lancet. 2024;403(10444):2597\u2013605.","journal-title":"Lancet"},{"issue":"1","key":"1211_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/1747493021991969","volume":"17","author":"M Sykora","year":"2022","unstructured":"Sykora M, Krebs S, Simader F, et al. Intravenous thrombolysis in stroke with admission NIHSS score 0 or 1. Int J Stroke. 2022;17(1):109\u201319.","journal-title":"Int J Stroke"},{"issue":"9","key":"1211_CR10","doi-asserted-by":"publisher","first-page":"e933","DOI":"10.1212\/WNL.0000000000207538","volume":"101","author":"M Sykora","year":"2023","unstructured":"Sykora M, Krebs S, Miksova D, et al. IV thrombolysis vs early dual antiplatelet therapy in patients with mild noncardioembolic ischemic stroke. Neurology. 2023;101(9):e933\u20139.","journal-title":"Neurology"},{"issue":"6","key":"1211_CR11","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1177\/1747493019832998","volume":"14","author":"XH Wang","year":"2019","unstructured":"Wang XH, Tao L, Zhou ZH, et al. Antiplatelet vs. R-tPA for acute mild ischemic stroke: a prospective, random, and open label multi-center study. Int J Stroke. 2019;14(6):658\u201363.","journal-title":"Int J Stroke"},{"issue":"12","key":"1211_CR12","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2019;50(12):e344\u2013418.","journal-title":"Stroke"},{"issue":"1","key":"1211_CR13","doi-asserted-by":"publisher","first-page":"I","DOI":"10.1177\/2396987321989865","volume":"6","author":"E Berge","year":"2021","unstructured":"Berge E, Whiteley W, Audebert H, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021;6(1):I\u2013LXII.","journal-title":"Eur Stroke J"},{"issue":"2","key":"1211_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/svn-2020-000378","volume":"5","author":"L Liu","year":"2020","unstructured":"Liu L, Chen W, Zhou H, et al. Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases. Stroke Vasc Neurol. 2020;5(2):159\u201376.","journal-title":"Stroke Vasc Neurol"},{"issue":"3","key":"1211_CR15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1177\/0271678X19836288","volume":"40","author":"P Seners","year":"2020","unstructured":"Seners P, Turc G, Lion S, et al. Relationships between brain perfusion and early recanalization after intravenous thrombolysis for acute stroke with large vessel occlusion. J Cereb Blood Flow Metab. 2020;40(3):667\u201377.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"1211_CR16","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1161\/STROKEAHA.120.032809","volume":"52","author":"JG Romano","year":"2021","unstructured":"Romano JG, Gardener H, Campo-Bustillo I, et al. Predictors of outcomes in patients with mild ischemic stroke symptoms: MaRISS. Stroke. 2021;52(6):1995\u20132004.","journal-title":"Stroke"},{"issue":"6","key":"1211_CR17","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1111\/cns.14124","volume":"29","author":"C Duan","year":"2023","unstructured":"Duan C, Xiong Y, Gu H, et al. Intravenous thrombolysis versus antiplatelet therapy in minor stroke patients with large vessel occlusion. CNS Neurosci Ther. 2023;29(6):1615\u201323.","journal-title":"CNS Neurosci Ther"},{"issue":"7","key":"1211_CR18","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1161\/STROKEAHA.124.047156","volume":"55","author":"E Doche","year":"2024","unstructured":"Doche E, Sulowski C, Guigonis JM, et al. How clot composition influences fibrinolysis in the acute phase of stroke: a proteomic study of cerebral thrombi. Stroke. 2024;55(7):1818\u201329.","journal-title":"Stroke"},{"issue":"26","key":"1211_CR19","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1056\/NEJMoa2309137","volume":"389","author":"Y Gao","year":"2023","unstructured":"Gao Y, Chen W, Pan Y, et al. Dual antiplatelet treatment up to 72 hours after ischemic stroke. N Engl J Med. 2023;389(26):2413\u201324.","journal-title":"N Engl J Med"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01211-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-025-01211-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01211-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T14:01:36Z","timestamp":1757512896000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-025-01211-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1211"],"URL":"https:\/\/doi.org\/10.1007\/s40263-025-01211-6","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"21 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was supported by grants from the Science and Technology Project Plan of Liaoning Province (2024JH6\/100700015). The funders of the study had no role in the study design, data collection, data analysis, data interpretation or writing of the report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"T.Nguyen discloses Associate Editorship of Stroke; advisory board for Brainomix, Aruna Bio; speaker for Genentech, Kaneka. Z.X.F. and Y.Y declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"H.S.C. contributed to the conception and design of the study, and critically revised the manuscript; Z.X.F. and Y.Y. contributed to analysis of data and drafting the text. Y.C. contributed to analysis of data. T.N.N. critically revised the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability Statement"}},{"value":"This study was performed according to the Declaration of Helsinki and approved by the Ethics Committees of the General Hospital of Northern Theater Command. The ethics committee approval number is k(2018)22","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Written informed consent was obtained from the patient or their legally authorized representatives.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}